SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-024487
Filing Date
2022-11-10
Accepted
2022-11-10 16:17:32
Documents
61
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q bolt-20220930.htm   iXBRL 10-Q 2678461
2 EX-31.1 bolt-ex31_1.htm EX-31.1 17728
3 EX-31.2 bolt-ex31_2.htm EX-31.2 17683
4 EX-32.1 bolt-ex32_1.htm EX-32.1 9372
5 EX-32.2 bolt-ex32_2.htm EX-32.2 10727
  Complete submission text file 0000950170-22-024487.txt   8502739

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bolt-20220930_lab.xml EX-101.LAB 406184
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bolt-20220930_cal.xml EX-101.CAL 44441
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bolt-20220930_pre.xml EX-101.PRE 297181
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bolt-20220930.xsd EX-101.SCH 55652
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bolt-20220930_def.xml EX-101.DEF 154403
55 EXTRACTED XBRL INSTANCE DOCUMENT bolt-20220930_htm.xml XML 1610349
Mailing Address 900 CHESAPEAKE DRIVE REDWOOD CITY CA 94063
Business Address 900 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 650-665-9295
Bolt Biotherapeutics, Inc. (Filer) CIK: 0001641281 (see all company filings)

IRS No.: 472804636 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39988 | Film No.: 221377475
SIC: 2834 Pharmaceutical Preparations